2004N-0355 - Scientific Considerations Related to Developing Biotechnology Products
FDA Comment Number : EC11
Submitter : Dr. Mathias Hukkelhoven Date & Time: 11/16/2004 06:11:04
Organization : Novartis Pharmaceuticals Corporation
Drug Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
See Attachment -- Comments Submitted On Behalf Of The Novartis Group Of Companies